INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2015

Evidence for the clinical effectiveness of pomegranate products in cancer treatment is poor due to poor study quality.

Researchers conducted two systematic reviews evaluating the effectiveness and safety of pomegranate products for cancer treatment, alongside product compositional analyses. Four clinical studies investigating three pomegranate products were identified, with one study considered inappropriate due to low polyphenol content. The evidence of clinical effectiveness was poor because study quality was poor. While the doses used in clinical studies showed no safety concerns, pomegranate preparations may induce synthetic drug metabolism through liver enzyme activation.

Study type
Two systematic reviews and product composition analysis
Who was studied
Participants across 4 identified clinical studies
What was measured
Effectiveness in cancer treatment and safety/toxicity of pomegranate products

THE PAPER

Efficacy and safety of pomegranate medicinal products for cancer.

Vlachojannis C, Zimmermann BF, Chrubasik-Hausmann S. Evid Based Complement Alternat Med, 2015.

PubMed 25815026 ↗DOI 10.1021/jf061674h ↗

CancerFood safety & contaminants

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.